logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Idiopathic Hypogonadotropic Hypogonadism

    FiltersReset Filters
    13 results

    • azmiro

      (TESTOSTERONE CYPIONATE)
      Azurity Pharmaceuticals, Inc.
      Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.

    • depo-testosterone

      (testosterone cypionate)
      Pharmacia and Upjohn Company LLC
      Usage: DEPO-Testosterone Injection is indicated for replacement therapy in men with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., gonadotropin deficiency). Its safety and efficacy for "age-related hypogonadism" have not been established.

    • kyzatrex

      (TESTOSTERONE UNDECANOATE)
      Marius Pharmaceuticals
      Usage: KYZATREX™ is indicated for testosterone replacement therapy in adult males with testosterone deficiency due to primary hypogonadism (e.g., testicular failure) or hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). Safety and efficacy in males under 18 have not been established.

    • methyltestosterone

      (METHYLTESTOSTERONE)
      Amneal Pharmaceuticals of New York LLC
      Usage: Androgens are indicated for testosterone replacement therapy in males with primary and hypogonadotropic hypogonadism, and for stimulating puberty in selected cases. In females, they are used in treating advanced inoperable metastatic breast cancer post-menopause. Treatment decisions should involve expert judgment, especially in oncology.

    • pregnyl

      (CHORIOGONADOTROPIN ALFA)
      Organon LLC
      Usage: hCG is indicated for prepubertal cryptorchidism not due to anatomical obstruction, selected cases of hypogonadotropic hypogonadism in males, and induction of ovulation in anovulatory, infertile women after appropriate treatment with human gonadotropins. It is not effective for weight loss or obesity treatment.

    • testosterone

      (Testosterone)
      Dr. Reddy's Laboratories Inc.
      Usage: Testosterone gel 1.62% is indicated for replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to conditions like testicular failure or pituitary-hypothalamic injury. Its safety and efficacy for age-related hypogonadism and in males under 18 have not been established.

    • testosterone

      (Testosterone)
      Upsher-Smith Laboratories, LLC
      Usage: Testosterone gel is indicated for replacement therapy in adult males with testosterone deficiency due to primary or hypogonadotropic hypogonadism. Conditions include testicular failure, pituitary-hypothalamic injury, and other related conditions. Safety and efficacy in age-related hypogonadism and in males under 18 have not been established.

    • testosterone

      (Testosterone)
      Actavis Pharma, Inc.
      Usage: Testosterone topical solution is indicated for replacement therapy in males with conditions caused by deficiency or absence of endogenous testosterone, including primary and hypogonadotropic hypogonadism. Its safety and efficacy in age-related hypogonadism or males under 18 have not been established.

    • testosterone

      (Testosterone)
      Lupin Pharmaceuticals Inc
      Usage: Testosterone topical solution USP is indicated for replacement therapy in males with primary or hypogonadotropic hypogonadism due to conditions like testicular failure or pituitary-hypothalamic injury. Efficacy in age-related hypogonadism and males under 18 has not been established.

    • testosterone cypionate

      (testosterone cypionate)
      Cipla USA Inc.
      Usage: Testosterone cypionate injection is indicated for replacement therapy in males with testosterone deficiency due to primary or hypogonadotropic hypogonadism, including conditions like testicular failure or pituitary-hypothalamic injury. Its safety and efficacy for age-related hypogonadism are not established.